TFF PHARMACEUTICALS, INC. Form DEFA14A: Additional definitive proxy soliciting materials
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-02-04: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIALS; Document ea0229913-defa14a_tffpharma.htm.
- 2024-04-22: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIALS; Document ea0204281-defa14a_tffpharma.htm.
- 2023-10-04: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIALS; Document ea186263-defa14a_tffpharma.htm.
- 2022-10-06: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIALS; Document ea166858-defa14a_tffpharma.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-02-04 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea0229913-defa14a_tffpharma.htm | |
| 2024-04-22 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea0204281-defa14a_tffpharma.htm | |
| 2023-10-04 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea186263-defa14a_tffpharma.htm | |
| 2022-10-06 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea166858-defa14a_tffpharma.htm |